rs7435827
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001077.4(UGT2B17):c.1313+1451T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.48 ( 22680 hom., cov: 19)
Consequence
UGT2B17
NM_001077.4 intron
NM_001077.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.87
Publications
4 publications found
Genes affected
UGT2B17 (HGNC:12547): (UDP glucuronosyltransferase family 2 member B17) This gene encodes a member of the uridine diphosphoglucuronosyltransferase protein family. The encoded enzyme catalyzes the transfer of glucuronic acid from uridine diphosphoglucuronic acid to a diverse array of substrates including steroid hormones and lipid-soluble drugs. This process, known as glucuronidation, is an intermediate step in the metabolism of steroids. Copy number variation in this gene is associated with susceptibility to osteoporosis.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.644 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001077.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| UGT2B17 | NM_001077.4 | MANE Select | c.1313+1451T>C | intron | N/A | NP_001068.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| UGT2B17 | ENST00000317746.3 | TSL:1 MANE Select | c.1313+1451T>C | intron | N/A | ENSP00000320401.2 |
Frequencies
GnomAD3 genomes AF: 0.483 AC: 58545AN: 121320Hom.: 22688 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
58545
AN:
121320
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.482 AC: 58525AN: 121382Hom.: 22680 Cov.: 19 AF XY: 0.477 AC XY: 27475AN XY: 57578 show subpopulations
GnomAD4 genome
AF:
AC:
58525
AN:
121382
Hom.:
Cov.:
19
AF XY:
AC XY:
27475
AN XY:
57578
show subpopulations
African (AFR)
AF:
AC:
6096
AN:
35932
American (AMR)
AF:
AC:
5691
AN:
11608
Ashkenazi Jewish (ASJ)
AF:
AC:
1852
AN:
2914
East Asian (EAS)
AF:
AC:
735
AN:
1258
South Asian (SAS)
AF:
AC:
1307
AN:
2530
European-Finnish (FIN)
AF:
AC:
3743
AN:
6670
Middle Eastern (MID)
AF:
AC:
174
AN:
236
European-Non Finnish (NFE)
AF:
AC:
37631
AN:
57914
Other (OTH)
AF:
AC:
887
AN:
1630
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
664
1327
1991
2654
3318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1101
AN:
1862
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.